Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

The Anti-Aging Effects of Adipose-Derived Mesenchymal Stem Cell Exosomes on Skin and Their Potential for Personalized Skincare Applications.

Jin YX., Jin GZ.

Narrative Review on Skin Aging, published in Clin Cosmet Investig Dermatol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Clin Cosmet Investig Dermatol (2025)
Country
New Zealand
Reported sample size
—
Source database
PubMed
PMID
40963883
PMCID
PMC12439826
DOI
10.2147/CCID.S547675
Citations
1

Abstract (original English)

Stem cell-derive exosomes have gained increasing attention in the skincare industry in recent years due to their multiple anti-aging benefits. However, differences in cell sources lead to significant heterogeneity in the composition of secreted exosomes, resulting in inconsistent biological effects. Moreover, the lack of standardized production protocols and the technical challenges associated with large-scale manufacturing continue to limit their broader application in the beauty industry. As a narrative review, this article systematically summarizes the biological functions and mechanisms of action of autologous adipose mesenchymal stem cell-derived exosomes (AMSCs-Exos) in anti-skin aging, covering in vitro, in vivo, and clinical studies. Recent studies have shown that autologous exosomes derived from AMSCs not only possess the common bioactivity shared by stem cell-derived exosomes but also exhibit higher biocompatibility and a lower risk of pathogen transmission. In addition, their suitability for small-scale production makes them a more advantageous option. Furthermore, advances in artificial intelligence (AI) technology are driving the transformation of the cosmetics industry from traditional skincare to personalized skincare: AI provides a basis for the personalized matching of exosome dosage and delivery methods through high-precision skin condition monitoring. It opti

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research